Search results for: Health Policy and Regulation
Filter search results
The State of Play for Cost-effectiveness Thresholds
28 June 2022
…Health Economics and Health Policy, we take stock of the research on supply-side cost-effectiveness thresholds. And we do so with policymakers in mind. Recent research to estimate supply-side thresholds is…
Employer Costs from Respiratory Infections
16 December 2024
…productivity has been studied across multiple conditions and recognised as a key policy issue (Schultz and Edington, 2007; Department for Work and Pensions and Department of Health and Social Care,…
To Hell with the 3L! NICE’s Missed Opportunity to Upgrade Health Outcome Measurement
2 March 2022
…describing health states in a way that is relevant across disease areas and health care settings. Its demonstrated ability to detect changes in health resulting from many (perhaps most) health…
Using Competition with Care: Comment on the Revised Regulations for the NHS
19 March 2013
…of health care funded by the NHS in England. OHE’s Jon Sussex has studied and written extensively on competition in the NHS. He was a member of the OHE Commission…
Europe’s pharmaceutical policy choices – And what the United States stands to learn
18 March 2026
…those trade-offs is the key lesson for policymakers on both sides of the Atlantic. Cost containment as a conscious policy choice Across most European health systems, healthcare is financed through…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
…regulatory pathways to support timely access to promising therapies in areas of high unmet medical need. On the other hand, Health Technology Assessment (HTA) and pricing and reimbursement (P&R) processes…
Unlocking the broader value of biologic therapies through biosimilar-enabled access and repositioning
23 September 2026
…bottom-up engagement with regional HTA, pharmacy, and clinical stakeholders; clinical-value systems (Germany) require demand-side policy — quotas, rebate contracts, automatic substitution — rather than reassessment; and market-based systems (US) require…
Around the world in HTAs: China – From fragmentation to function
2 September 2025
…informal and fragmented. In 2016 and 2017, the Ministry of Human Resources and Social Security and the National Health and Family Planning Commission (which is now the National Health Commission),…
The Dynamics of Drug Shortages
9 January 2024
…price change of other products with the same molecule, iii) market concentration, iv) demand and competition, and v) patent expiration), which can be used to determine shortages’ factors and value…